TAMPA, Fla., May 6 /PRNewswire/ --- With more than 223,000 American women estimated to be diagnosed with breast or gynecologic cancers in 2008, Moffitt Cancer Center is leading the current movement toward focusing more on personalized cancer care treatment techniques to break new ground within the field of women's oncology.
To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/moffittcancercenter/38208/
Dr. Johnathan Lancaster, an internationally known ovarian cancer researcher, is Director of The Center for Women's Oncology at Moffitt Cancer Center:
"We've now reached a point in cancer research and treatment that is really very exciting. Recent advancements in technology have increased the success rate of many surgical procedures, while decreasing a patients' recovery time and negative impacts on their quality of life. The most promising advancement is within the treatment of a patients' tumor by analyzing its genetic makeup. By identifying its biological fingerprint, we are now able to customize treatment, increasing the chances of success."
Facts about women's cancers:
Personalized cancer care treatment:
About Moffitt Cancer Center
Located in Tampa, Florida, Moffitt Cancer Center is the only Florida-based cancer center with the NCI designation as a Comprehensive Cancer Center for its excellence in research and contributions to clinical trials, prevention and cancer control. Moffitt currently has 15 affiliates in Florida, one in Georgia and two in Puerto Rico. Additionally, Moffitt is a member of the National Comprehensive Cancer Network, a prestigious alliance of the country's leading cancer centers, and is listed in U.S. News & World Report as one of "America's Best Hospitals" for cancer. Moffitt's sole mission is to contribute to the prevention and cure of cancer.
|SOURCE Moffitt Cancer Center|
Copyright©2009 PR Newswire.
All rights reserved